ATE425748T1 - Verwendung von neboglamin bei der behandlung von abhangigkeit von toxischen substanzen - Google Patents

Verwendung von neboglamin bei der behandlung von abhangigkeit von toxischen substanzen

Info

Publication number
ATE425748T1
ATE425748T1 AT06809478T AT06809478T ATE425748T1 AT E425748 T1 ATE425748 T1 AT E425748T1 AT 06809478 T AT06809478 T AT 06809478T AT 06809478 T AT06809478 T AT 06809478T AT E425748 T1 ATE425748 T1 AT E425748T1
Authority
AT
Austria
Prior art keywords
neboglamin
toxic substances
dependency
treating
treating dependency
Prior art date
Application number
AT06809478T
Other languages
English (en)
Inventor
Francesco Makovec
Gianfranco Caselli
Lucio Claudio Rovati
Antonio Giordani
Original Assignee
Rottapharm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rottapharm Spa filed Critical Rottapharm Spa
Application granted granted Critical
Publication of ATE425748T1 publication Critical patent/ATE425748T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Addiction (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06809478T 2005-10-04 2006-10-03 Verwendung von neboglamin bei der behandlung von abhangigkeit von toxischen substanzen ATE425748T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000691A ITTO20050691A1 (it) 2005-10-04 2005-10-04 Uso di neboglamine nella terapia delle tossicodipendenze

Publications (1)

Publication Number Publication Date
ATE425748T1 true ATE425748T1 (de) 2009-04-15

Family

ID=37814217

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06809478T ATE425748T1 (de) 2005-10-04 2006-10-03 Verwendung von neboglamin bei der behandlung von abhangigkeit von toxischen substanzen

Country Status (10)

Country Link
US (2) US20100197962A1 (de)
EP (1) EP1940376B1 (de)
JP (1) JP2009510158A (de)
AT (1) ATE425748T1 (de)
AU (1) AU2006298393B2 (de)
CA (1) CA2624449C (de)
DE (1) DE602006005831D1 (de)
ES (1) ES2323982T3 (de)
IT (1) ITTO20050691A1 (de)
WO (1) WO2007039869A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12458906B2 (en) 2018-01-23 2025-11-04 High Sierra Technologies, Inc. Methods of modifying a naturally occurring cannabis raw plant material, a purified cannabis product from a naturally occurring cannabis raw plant material, and a modified cannabis product from a naturally occurring cannabis raw plant material
CA3031123C (en) 2018-01-23 2023-11-07 High Sierra Technologies, Inc. Cannabis products modified by removing volatile organic compounds and adding volatile unsaturated hydrocarbons

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9024738D0 (en) * 1990-11-14 1991-01-02 Erba Carlo Spa A new method of treatment of tumor necroisis factor(tnf)-related diseases
GB9109007D0 (en) * 1991-04-26 1991-06-12 Merck Sharp & Dohme Therapeutic method
IT1264765B1 (it) * 1993-03-10 1996-10-04 Rotta Research Lab Derivati dell'acido glutammico ed acido aspartico, procedimento per la loro preparazione e loro uso come farmaci potenzianti la
US5523323A (en) * 1993-09-14 1996-06-04 Maccecchini; Maria-Luisa Use of partial agonists of the NMDA receptor to reduce opiate induced tolerance and dependence
ITTO20040343A1 (it) * 2004-05-24 2004-08-24 Rotta Res Lab Spa Uso di neboglamine (cr2249) come neuropsicotico e neuroprotettivo

Also Published As

Publication number Publication date
US8258185B2 (en) 2012-09-04
ES2323982T3 (es) 2009-07-28
ITTO20050691A1 (it) 2007-04-05
CA2624449C (en) 2013-12-17
DE602006005831D1 (de) 2009-04-30
US20110288173A1 (en) 2011-11-24
WO2007039869A2 (en) 2007-04-12
JP2009510158A (ja) 2009-03-12
EP1940376A2 (de) 2008-07-09
WO2007039869A3 (en) 2007-07-05
AU2006298393A1 (en) 2007-04-12
US20100197962A1 (en) 2010-08-05
CA2624449A1 (en) 2007-04-12
EP1940376B1 (de) 2009-03-18
AU2006298393B2 (en) 2011-04-14

Similar Documents

Publication Publication Date Title
DE602004029580D1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
ATE550338T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
IL171977A (en) Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same
BRPI0508051A (pt) derivados de heteroarilaminopirazol utilizáveis para o tratamento de diabetes
BRPI0408863A (pt) composto, composição farmacêutica, método para tratar doenças, e, uso de um composto.
BRPI0510084A (pt) benzoxazina para tratamento de doenças do trato respiratório
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
ATE539754T1 (de) Arzneinmittelkombinationen enthaltend benzoxazine zur behandlung von atemwegserkrankungen
WO2005090296A3 (en) N-substituted benzene sulfonamides
WO2007024651A3 (en) Bridged n-bicyclic sulfonamido inhibitors of gamma secretase
ATE457027T1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht
CL2004001068A1 (es) Compuestos derivados de 2,3,4,5-tetrahidrobenzo[f][1,4]oxazepina; procedimientos de preparacion; composicion farmaceutica que los contiene y su uso en la elaboracion de un medicamento util para el tratamiento de la enfermedad de alzheimer.
EA200900269A1 (ru) Лекарственные комбинации для лечения заболеваний дыхательных путей
BR0105787A (pt) Composição farmacêutica, uso de um composto farmacêutico, método para tratamento de distúrbios, composto farmacêutico e método para confeccionar um composto farmacêutico
ATE425748T1 (de) Verwendung von neboglamin bei der behandlung von abhangigkeit von toxischen substanzen
DE602006005640D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit
EA200701856A1 (ru) Тетрагидропиридоазепин-8-оны и родственные соединения для лечения шизофрении
UY29741A1 (es) Sales de 1,5- diaril pirazol-3-carboxamidas, procesos de preparación, composeciones farmacéuticas que las contienen, aplicaciones y métodos de uso.
EA200701615A1 (ru) Новые лекарственные средства для лечения заболеваний дыхательных путей
DE602004025935D1 (de) Histondeacetylaseinhibitor und verfahren zu dessen herstellung
DE602006002608D1 (de) 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit
AR072810A1 (es) Compuesto de 3-( 4 fenilsulfonil-1-piperazinil) carbonil) pirazolo(1,5 -a) pirimidina , composicion farmaceutica que lo comprende y su uso para la fabricacion de un medicamento para el tratamiento del dolor.
DE602004020337D1 (de) Anticholinergika enthaltende Arzneimittel zur Behandlung von Krankheiten der ableitenden Harnwege
DE502007006951D1 (de) Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
DK1716128T3 (da) Substituerede 4,5,6,7-tetrahydrobenzothiazol-2-ylaminforbindelser

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties